Sonic Healthcare (ASX:SHL) share price on watch after 149% profit boost in FY21

After rallying 30% year-to-date, Sonic Healthcare share price will be put to the test after the release of the company's FY21 results.

| More on:
female nurse in scrubs

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Sonic Healthcare Limited (ASX: SHL) share price will be in the spotlight on Monday after the company released its FY21 full-year results this morning.

Sonic Healthcare share price in focus after bumper profit result

The Sonic Healthcare share price could be a mover following a well-rounded financial performance in FY21. Key highlights include:

What happened for Sonic Healthcare in FY21?

The Sonic Healthcare share price has rallied strongly in FY21, thanks to its resilient base business and active role in combating the COVID-19 pandemic.

The company has performed approximately 30 million COVID-19 PCR tests to date across ~60 Sonic laboratories globally.

The results noted that COVID-19 PCR volumes were lower in the second half of the year versus the first half, but have been increasing post-year end with the spread of the Delta variant.

Its base business revenue (excluding COVID testing) grew 6% compared to FY20 and was up 4% versus FY19.

Sonic Healthcare's EBITDA surged 81%, again enhanced by COVID-19 testing and leveraging existing infrastructure. The company's laboratory businesses across ANZ, USA and Europe contribute approximately 88% of Group revenues, and the company was pleased to highlight a significant improvement in EBITDA margins

EBITDA margins for its Laboratory division increased from 21.3% to 30.8%. At the same time, Sonic Healthcare's medical imaging business reported 24% EBITDA growth and 108 basis points of margin improvement.

Management commentary

Sonic Healthcare's CEO Dr Colin Goldschmidt commented on the results, saying:

As a global healthcare organisation, we have continued to play a major role in combating the COVID19 pandemic, by providing 30 million PCR tests and over 2 million serology tests to date. We are also proud to be the largest non-government provider of COVID-19 vaccinations in Australia.

Goldschmidt also shed light on the company's strategic focus on acquisitions:

In addition to organic growth, Sonic continues to focus on synergistic acquisitions and other growth opportunities, supported by our current record low gearing levels, geographic footprint, leading market positions and brands, and our deeply embedded Medical Leadership culture. We were delighted to recently announce the pending acquisition of Canberra Imaging Group, following on from our move in March 2021 to majority ownership of Epworth Medical Imaging. We are actively considering further acquisition opportunities, as well as bidding for a number of outsourcing contracts.

What's next for Sonic Healthcare?

The Sonic Healthcare share price has rallied strongly this year, up 30% year-to-date.

The company advised that it will not provide earnings guidance for FY22 due to COVID-19 related unpredictability:

"The pandemic has the potential to cause fluctuations in both COVID-19 testing revenues and the base business, although the base business has become increasingly resilient to the impacts of pandemic waves. The underlying growth drivers for healthcare services remain unchanged. Base business fluctuations are also mitigated by geographical and business sector diversity. The COVID-19 Delta variant is currently driving increases in COVID-19 testing revenues."

Motley Fool contributor Kerry Sun has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Sonic Healthcare Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Earnings Results

Delighted adult man, working on a company slogan, on his laptop.
Earnings Results

Bank of Queensland share price leaps 6% on improving outlook

ASX 200 investors are bidding up the Bank of Queensland share price on Wednesday.

Read more »

Photo of two women shopping.
Earnings Results

Premier Investments share price jumps 9% on results and demerger plans

The Smiggle and Peter Alexander owner has released its results. How did it perform?

Read more »

A man holds his hand under his chin as he concentrates on his laptop screen and reads about the ANZ share price
Earnings Results

Soul Patts share price struggles on falling profits

ASX 200 investment house Soul Patts reported its half year results this morning.

Read more »

a biomedical researcher sits at his desk with his hand on his chin, thinking and giving a small smile with a microscope next to him and an array of test tubes and beackers behind him on shelves in a well-lit bright office.
Earnings Results

Chemist Warehouse merger target Sigma reports 149% FY24 profit jump

This could be the last set of results from Sigma as we know it if its merger is approved.

Read more »

A man holds his head in his hands, despairing at the bad result he's reading on his computer.
Earnings Results

Brickworks share price tumbles on disappointing half-year loss

This loss didn't stop the company from increasing its dividend again.

Read more »

A man sits on a bench atop a mountain with a laptop, making investments with a green ESG mind.
Earnings Results

ASX All Ords stock KMD tumbles as interim dividend cancelled

Investors are hitting the sell button on ASX All Ords stock KMD today.

Read more »

Coal miner holding a giant coal rock in his hand making a circle with his hand, symbolising a rising share price.
Energy Shares

New Hope share price charges higher despite profit crunch and huge dividend cut

Weaker coal prices have hit this miner's profits and dividend hard.

Read more »

A Chinese investor sits in front of his laptop looking pensive and concerned about pandemic lockdowns which may impact ASX 200 iron ore share prices
Earnings Results

Liontown share price tumbles 7% on half-year results

This lithium developer's results have been released this afternoon.

Read more »